×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
Benefit-risk assessment for initial marketing ... · – Surrogate endpoints? ... – SmPCs are a key part of the marketing authorisation of all medicines authorised in the European
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form